<VariationArchive RecordType="classified" VariationID="162431" VariationName="NM_002617.4(PEX10):c.337del (p.Leu113fs)" VariationType="Deletion" Accession="VCV000162431" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-12-30" DateCreated="2018-08-16" MostRecentSubmission="2023-12-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="172122" VariationID="162431">
      <GeneList>
        <Gene Symbol="PEX10" FullName="peroxisomal biogenesis factor 10" GeneID="5192" HGNC_ID="HGNC:8851" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="2403974" stop="2413827" display_start="2403974" display_stop="2413827" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="2336240" stop="2344009" display_start="2336240" display_stop="2344009" Strand="-" />
          </Location>
          <OMIM>602859</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002617.4(PEX10):c.337del (p.Leu113fs)</Name>
      <CanonicalSPDI>NC_000001.11:2408714:GGGGG:GGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="2408715" stop="2408715" display_start="2408715" display_stop="2408715" variantLength="1" positionVCF="2408714" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="2340154" stop="2340154" display_start="2340154" display_stop="2340154" variantLength="1" positionVCF="2340153" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L113fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.2340158del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.2340158del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.2408719del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.2408719del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008342.1" sequenceAccession="NG_008342" sequenceVersion="1" change="g.8857del">
            <Expression>NG_008342.1:g.8857del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374425.1" sequenceAccession="NM_001374425" sequenceVersion="1" change="c.337del">
            <Expression>NM_001374425.1:c.337del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361354.1" sequenceAccession="NP_001361354" sequenceVersion="1" change="p.Leu113fs">
            <Expression>NP_001361354.1:p.Leu113fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374426.1" sequenceAccession="NM_001374426" sequenceVersion="1" change="c.-96del">
            <Expression>NM_001374426.1:c.-96del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374427.1" sequenceAccession="NM_001374427" sequenceVersion="1" change="c.-96del">
            <Expression>NM_001374427.1:c.-96del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002617.4" sequenceAccession="NM_002617" sequenceVersion="4" change="c.337del" MANESelect="true">
            <Expression>NM_002617.4:c.337del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002608.1" sequenceAccession="NP_002608" sequenceVersion="1" change="p.Leu113fs">
            <Expression>NP_002608.1:p.Leu113fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153818.2" sequenceAccession="NM_153818" sequenceVersion="2" change="c.337del">
            <Expression>NM_153818.2:c.337del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_722540.1" sequenceAccession="NP_722540" sequenceVersion="1" change="p.Leu113fs">
            <Expression>NP_722540.1:p.Leu113fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_164636.1" sequenceAccession="NR_164636" sequenceVersion="1" change="n.456del">
            <Expression>NR_164636.1:n.456del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA175036" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602859.0007" DB="OMIM" />
        <XRef Type="rs" ID="724159999" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002617.4(PEX10):c.337del (p.Leu113fs) AND Peroxisome biogenesis disorder 6B" Accession="RCV000149809" Version="5">
        <ClassifiedConditionList TraitSetID="8955">
          <ClassifiedCondition DB="MedGen" ID="C3553948">Peroxisome biogenesis disorder 6B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002617.4(PEX10):c.337del (p.Leu113fs) AND Peroxisome biogenesis disorder 6A (Zellweger)" Accession="RCV003474798" Version="1">
        <ClassifiedConditionList TraitSetID="8954">
          <ClassifiedCondition DB="MedGen" ID="C3553947">Peroxisome biogenesis disorder 6A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-17" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-08-16" MostRecentSubmission="2023-12-30">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19127411</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8982949</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8954" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17434" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 6A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 6A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013936" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD6A</ElementValue>
                <XRef ID="GTR000522761" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614870" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 7 (CG7, equivalent to CGB) have mutations in the PEX10 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614870" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15864" />
                <XRef ID="15864" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3553947" DB="MedGen" />
              <XRef ID="MONDO:0013936" DB="MONDO" />
              <XRef Type="MIM" ID="614870" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8955" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17435" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 6B</ElementValue>
                <XRef ID="MONDO:0013937" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD6B</ElementValue>
                <XRef Type="MIM" ID="614871" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15865" />
                <XRef ID="15865" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="C3553948" DB="MedGen" />
              <XRef ID="MONDO:0013937" DB="MONDO" />
              <XRef Type="MIM" ID="614871" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="351680" SubmissionDate="2018-08-13" DateLastUpdated="2018-08-16" DateCreated="2015-01-17">
        <ClinVarSubmissionID localKey="602859.0007_PEROXISOME BIOGENESIS DISORDER 6B" title="PEX10, 1-BP DEL, 337C_PEROXISOME BIOGENESIS DISORDER 6B" />
        <ClinVarAccession Accession="SCV000196633" DateUpdated="2018-08-16" DateCreated="2015-01-17" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a young woman (PBD687) with a mild form of peroxisome biogenesis disorder 6B (PBD6B; 614871) manifest mainly as ataxia and nystagmus beginning in early childhood, previously reported by Clayton et al. (1996), Steinberg et al. (2009) identified compound heterozygous mutations in the PEX10 gene: a 1-bp deletion (c.337delC) resulting in a frameshift (Leu113fs) and premature termination at a codon 39 amino acids downstream, inherited from his unaffected father, and a c.890T-C transition, resulting in a leu297-to-pro (L297P; 602859.0008) substitution that apparently occurred de novo on the maternal allele. A c.880A-G transition resulting in a thr294-to-ala (T294A) substitution was also found on the paternal allele. The L297P substitution occurred at a highly conserved residue in the C3HC4 domain. In vitro studies of patient cultured fibroblasts showed no defects in peroxisome metabolism or assembly, but the patient had persistently increased plasma pipecolic acid as well as increased serum bile acid precursors, indicating impaired beta-oxidation of bile acid intermediates and consistent with a generalized defect in peroxisome assembly.</Attribute>
              <Citation>
                <ID Source="PubMed">8982949</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">19127411</ID>
              </Citation>
              <XRef DB="OMIM" ID="614871" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX10" />
          </GeneList>
          <Name>PEX10, 1-BP DEL, 337C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 337C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602859.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOME BIOGENESIS DISORDER 6B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7856098" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_153818.2:c.337del|OMIM:614870" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004201418" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153818.2:c.337del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614870" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="351680" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOME BIOGENESIS DISORDER 6B" MappingRef="Preferred">
        <MedGen CUI="C3553948" Name="Peroxisome biogenesis disorder 6B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7856098" TraitType="Disease" MappingType="XRef" MappingValue="614870" MappingRef="OMIM">
        <MedGen CUI="C3553947" Name="Peroxisome biogenesis disorder 6A (Zellweger)" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

